Who invested in Apexigen?
Apexigen's investors include 3E Bioventures, China Development Industrial Bank (CDIB), Decheng Capital, Sycamore Ventures and Amkey Ventures, and 2 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$30Mraised across 3 rounds since 2013, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finsmes.comSEC filing: $15M sold, first sale Apr 2013
From the SEC filings it signed: 6 on the team.
On the board, as filediDan ZabrowskiGordon RingoldHerb CrossJakob DupontSamuel WertheimerScott Smith
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Apexigen's investors include 3E Bioventures, China Development Industrial Bank (CDIB), Decheng Capital, Sycamore Ventures and Amkey Ventures, and 2 more on record.
Apexigen has raised $30M across 3 rounds since 2013.
Apexigen's most recent round was an Undisclosed round of $2.8M in Jan 2023.
Apexigen's largest round on record is $20M (Series A), in Aug 2013.
Apexigen's first round on record, in Aug 2013, was backed by China Development Industrial Bank (CDIB), Sycamore Ventures and Amkey Ventures and 2 others.
Apexigen's latest named round is an Undisclosed round, in Jan 2023.
Apexigen is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.